- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/193 - Equine encephalomyelitis virus
Patent holdings for IPC class A61K 39/193
Total number of patents in this class: 46
10-year publication summary
|
2
|
3
|
4
|
2
|
0
|
0
|
2
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intervet Inc. | 905 |
7 |
| Intervet International B.V. | 1301 |
6 |
| Boehringer Ingelheim Vetmedica, Inc. | 107 |
2 |
| Academia Sinica | 953 |
2 |
| AlphaVax, Inc. | 22 |
2 |
| Imperial College Innovations Limited | 614 |
2 |
| Medigen, Inc. | 17 |
2 |
| The University of North Carolina at Chapel Hill | 2059 |
2 |
| Seattle Project Corp. | 74 |
2 |
| Merck Sharp & Dohme Corp. | 2187 |
1 |
| Centre National de La Recherche Scientifique | 10726 |
1 |
| Life Technologies Corporation | 3356 |
1 |
| President and Fellows of Harvard College | 6044 |
1 |
| The Trustees of the University of Pennsylvania | 4382 |
1 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2224 |
1 |
| Her Majesty the Queen in Right of Canada, as represented by the Minister of National Defence | 201 |
1 |
| Institut Pasteur | 787 |
1 |
| Lentigen Corporation | 5 |
1 |
| Sanofi Pasteur Biologics Co. | 15 |
1 |
| The Secretary of State for Defence | 420 |
1 |
| Other owners | 8 |